These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1360793)

  • 1. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
    Gretler DD; Elliott WJ; Moscucci M; Childers RW; Murphy MB
    Arch Intern Med; 1992 Dec; 152(12):2445-8. PubMed ID: 1360793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
    Hackman BB; Griffin B; Mills M; Ramanathan KB
    Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
    de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
    Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans.
    Elliott WJ; Karnezis TA; Silverman RA; Geanon J; Tripathi RC; Murphy MB
    Clin Pharmacol Ther; 1991 Mar; 49(3):285-93. PubMed ID: 1672512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension.
    Pilmer BL; Green JA; Panacek EA; Elliot WJ; Murphy MB; Rutherford W; Nara AR
    J Clin Pharmacol; 1993 Jun; 33(6):549-53. PubMed ID: 8103527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
    Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
    Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
    Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
    Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of a specific dopaminergic receptor agonist with metoclopramide in horses.
    Eades SC; Moore JN
    Am J Vet Res; 1993 Jan; 54(1):122-5. PubMed ID: 8093992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intravenous fenoldopam (SK&F 82526-J) on blood pressure in severe hypertension. SK&F Fenoldopam Working Group.
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):445-6. PubMed ID: 1355665
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular responses in healthy subjects to a novel oral dopamine agonist, fenoldopam.
    Cregeen RJ; Rudge PJ; Mills JG; Vincent SH; Burland WL
    J Hypertens Suppl; 1985 Dec; 3(3):S173-5. PubMed ID: 2908814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
    Gretler DD; Jones KC; Murphy MB
    J Pharmacol Exp Ther; 1992 Feb; 260(2):491-8. PubMed ID: 1346635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fenoldopam on renal blood flow and systemic hemodynamics during isoflurane anesthesia.
    Aronson S; Goldberg LI; Glock D; Roth S; Moss J; Roizen MF
    J Cardiothorac Vasc Anesth; 1991 Feb; 5(1):29-32. PubMed ID: 1678284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
    Polak MJ; Taylor DA
    Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrocardiographic changes in patients with chronic anemia].
    Stanojević M; Stankov S
    Srp Arh Celok Lek; 1998; 126(11-12):461-6. PubMed ID: 9921020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.
    Munger MA; Rutherford WF; Anderson L; Hakki AI; Gonzalez FM; Bednarczyk EM; Emmanuel G; Weed SG; Panacek EA; Green JA
    Crit Care Med; 1990 May; 18(5):502-4. PubMed ID: 1970283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoldopam versus nitroprusside for the treatment of hypertensive emergency.
    Devlin JW; Seta ML; Kanji S; Somerville AL
    Ann Pharmacother; 2004 May; 38(5):755-9. PubMed ID: 15039472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.